Erratum: Results from the Survey of Antibiotic Resistance (SOAR) 2012–14 in Thailand, India, South Korea and Singapore (Journal of Antimicrobial Chemotherapy (2016) 71:Suppl 1 (i3-i19) DOI: 10.1093/jac/dkw073);Results from the Survey of Antibiotic Resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue , 2016, Pages i3-i19

  Torumkuney, D ^a   Chaiwarith, R ^b   Reechaipichitkul, W ^c   Malatham, K ^d   Chareonphaibul, V ^a   Rodrigues, C ^e   Chitins, D S ^f   Dias, M ^g   Anandan, S ^h   Kanakapura, S ⁱ   Park, Y J ^j   Lee, K ^k   Lee, H ^l   Kim, J Y ^l   Lee, Y ^m   Lee, H K ⁿ   Kim, J H ^a   Tan, T Y ^o   Heng, Y X ^o   Mukherjee, P ^p   Morrissey, I ^q   more..

^a GLAXOSMITHKLINE   (United Kingdom)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e P D HINDUJA NATIONAL HOSPITAL   (India)

^f CHOITHRAM HOSPITAL AND RESEARCH CENTRE   (India)

^g ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^h CHRISTIAN MEDICAL COLLEGE   (India)

ⁱ GlaxoSmithKline Pharmaceuticals Asia Pvt Ltd   (India)

^j The Catholic University of Korea   (South Korea)

^k Yonsei University College of Medicine   (South Korea)

^l Yonsei University College of Medicine   (South Korea)

^m Hanyang University Medical Center   (South Korea)

ⁿ Uijeongbu St Mary's Hospital   (South Korea)

^o CHANGI GENERAL HOSPITAL   (Singapore)

^p GLAXOSMITHKLINE   (Singapore)

^q International Health Management Associates Europe Sàrl   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; BERYTHROMYCIN; CEFACLOR; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; OFLOXACIN; PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; COMMUNITY ACQUIRED INFECTION; DISK DIFFUSION; EPSILOMETER TEST; HAEMOPHILUS INFLUENZAE; HEALTH SURVEY; HUMAN; INDIA; MAJOR CLINICAL STUDY; MORAXELLA CATARRHALIS; NONHUMAN; PREVALENCE; RESPIRATORY TRACT INFECTION; SINGAPORE; SOUTH KOREA; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; THAILAND; ANTIBIOTIC RESISTANCE; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTIONS; SOUTHEAST ASIA; STREPTOCOCCUS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ASIA, SOUTHEASTERN; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; HAEMOPHILUS INFLUENZAE; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS; YOUNG ADULT;

EID: 84964727100     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/JAC/DKW332     Document Type: Erratum

References (25)

1. World Health Organization World Health Part III. Global Health Indicators. http://www.who.int/gho/publications/world_health_statistics/ EN_WHS2014_Part3.pdf?ua=1.
2. Torres A, Blasi F, Peetermans WEet al. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis 2014; 33: 1065-79.
3. Riedel S, Beekmann SE, Heilmann KP et al. Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2007; 26: 485-90.
4. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: S79-87.
5. Bronzwaer SL, Cars O, Buchholz U et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278-82.
6. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67: 71-9.
7. Liam C-K, Pang Y-K, Poosparajah S et al. Community-acquired pneumonia: an Asia Pacific perspective. Respirology 2007; 12: 162-4.
8. Tleyjeh IM, Tlaygeh HM, Hejal R et al. The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis 2006; 42: 788-97.
9. Jacobs MR, Johnson CE. Macrolide resistance: an increasing concern for treatment failure in children. Pediatr Infect Dis J 2003; 22: S131-8.
10. Kang CI, Song JH, Kim SH. Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort. Infection 2013; 41: 151-7.
11. Kim SH, Song JH, Chung DR et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 2012; 56: 1418-26.
12. Lee S, Kim SH, Park M et al. High prevalence of multiresistance in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea. Diagn Microb Infect Dis 2013; 76: 227-31.
13. Chawla K, Gurung B, Mukhopadhyay C et al. Reporting emerging resistance of Streptococcus pneumoniae from India. J Glob Infect Dis 2010; 2: 10-4.
14. Bae S, Lee J, Kim E et al. Serotype distribution and b-lactam resistance in Haemophilus influenzae isolated from patients with respiratory infections in Korea. J Microbiol 2010; 48: 84-8.
15. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disc Susceptibility Tests-Twelfth Edition: Approved Standard M02-A12. CLSI, Wayne, PA, USA, 2015.
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fifth Informational Supplement M100-S25. CLSI, Wayne, PA, USA, 2015.
17. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 5.0, 2015. http://www.eucast.org.
18. Anon JB, Jacobs MR, Poole MD et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg. 2004; 130 Suppl 1: 1-45.
19. O'Brien D, Tan TY, Lee I. Antibacterial resistance among Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis from Singapore. Results from the Survey of Antibiotic Resistance (SOAR) 2009-2011. In: Abstracts of the 8th International Symposium on Antimicrobial Agents and Resistance, Seoul, Korea, 2011. Abstract P3-109.
20. Khantawa B, Baosount V, Warachit B et al. Antibacterial resistance among Streptococcus pneumoniae from 4 centres in Thailand: results from the Survey of Antibiotic Resistance (SOAR) 2007-2009. In: Abstracts of the 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, 2010. Abstract 2570. European Society for Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
21. Chandy SJ, Thomas K, Mathai E et al. Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, south India. J Antimicrob Chemother 2013; 68: 229-36.
22. Hoban D, Baquero F, Reed V et al. Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999-2000. Int J Infect Dis 2005; 9: 262-73.
23. Soyletir G, Altinkanat G, Gur D et al. Results fromthe Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey. J Antimicrob Chemother 2016; 71 Suppl 1: i71-i83.
24. Van PH, Binh PT, Minh NHL et al. Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam. J Antimicrob Chemother 2016; 71 Suppl 1: i93-i102.
25. Marchese A, Esposito S, Barbieri R et al. Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections? BMC Infect Dis 2012; 12: 181-90.